New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week

Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

COVID-19: Drug Targets and Potential Treatments

NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020

COVID-19 therapeutics: Challenges and directions for the future

Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases - ScienceDirect

Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID

Two Years into the COVID-19 Pandemic: Lessons Learned

NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies

Coronavirus Drug and Treatment Tracker - The New York Times